Literature DB >> 28664300

Brachytherapy in the treatment of breast cancer.

Xinna Deng1, Haijiang Wu2, Fei Gao1, Ye Su3,4, Qingxia Li1, Shuzhen Liu1, Jianhui Cai5.   

Abstract

Brachytherapy is an important radio-therapeutic modality for a variety of malignancies, including prostate cancer, cervix cancer, breast cancer, vagina cancer, endometrium cancer, head and neck cancer, and many more. This technique has been shown to be an effective and safe non-pharmaceutical treatment with fewer serious complications and better outcome than other treatments for breast cancer. Every year, hundreds of thousands of patients around the world benefit from brachytherapy, which reliably delivers a relatively higher radiation dose to the intended target. However, the follow-up time, patient eligibility criteria, treatment strategy, and radiation doses used in published studies are somewhat inconsistent, making it difficult to strictly compare and evaluate the performance of the treatment. More rigorous studies are required to confirm the safety of this technique and to make outcome data more comparable. In this review, we focus on recent advances in breast brachytherapy techniques and provide an overview of outcomes, cosmetic outcome, toxicity, complications, and limitations of brachytherapy for the treatment of breast cancer. We also summarize the clinical outcomes and toxicity results in patients receiving or not receiving brachytherapy.

Entities:  

Keywords:  Brachytherapy; Breast cancer; Outcomes; Radiation therapy

Mesh:

Year:  2017        PMID: 28664300     DOI: 10.1007/s10147-017-1155-5

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  75 in total

1.  First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.

Authors:  Frank A Vicini; Peter D Beitsch; Coral A Quiet; Angela Keleher; Delia Garcia; Howard C Snider; Mark A Gittleman; Victor J Zannis; H Kuerer; Eric B Whitacre; Pat W Whitworth; Richard E Fine; Bruce G Haffty; L Stacey Arrambide
Journal:  Cancer       Date:  2005-09-15       Impact factor: 6.860

2.  Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.

Authors:  Matthew M Mille; X George Xu; Mark J Rivard
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

3.  Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.

Authors:  Daniela Kauer-Dorner; Richard Pötter; Alexandra Resch; Leonore Handl-Zeller; Kathrin Kirchheiner; Katja Meyer-Schell; Wolfgang Dörr
Journal:  Radiother Oncol       Date:  2011-09-08       Impact factor: 6.280

4.  Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer.

Authors:  F A Vicini; L L Kestin; G K Edmundson; D A Jaffray; J W Wong; V R Kini; P Y Chen; A A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

5.  Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.

Authors:  Sharad Goyal; Atif J Khan; Frank Vicini; Peter D Beitsch; Maureen Lyden; Martin Keisch; Bruce G Haffty
Journal:  Ann Surg Oncol       Date:  2009-06-11       Impact factor: 5.344

6.  Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.

Authors:  J Vito Antonucci; Michelle Wallace; Neal S Goldstein; Larry Kestin; Peter Chen; Pamela Benitez; Nayana Dekhne; Alvaro Martinez; Frank Vicini
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-06       Impact factor: 7.038

7.  Dosimetric parameters in partial breast irradiation through brachytherapy.

Authors:  Aime Gloi; Steve McCourt; Robert Buchanan; Andrea Goetller; Corrie Zuge; Paula Balzoa; Greg Cooley
Journal:  Med Dosim       Date:  2008-09-21       Impact factor: 1.482

8.  Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.

Authors:  John M Watkins; Jennifer L Harper; Anthony E Dragun; Michael S Ashenafi; Debajyoti Sinha; Jun Li; David J Cole; Joseph M Jenrette
Journal:  Brachytherapy       Date:  2008-09-07       Impact factor: 2.362

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation.

Authors:  Daniel J Ferraro; Adam A Garsa; Todd A DeWees; Julie A Margenthaler; Michael Naughton; Rebecca Aft; William E Gillanders; Timothy Eberlein; Melissa A Matesa; Imran Zoberi
Journal:  Radiat Oncol       Date:  2012-03-29       Impact factor: 3.481

View more
  8 in total

Review 1.  Role of Exosomes for Delivery of Chemotherapeutic Drugs.

Authors:  Aragaw Gebeyehu; Nagavendra Kommineni; David G Meckes; Mandip Singh Sachdeva
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2021       Impact factor: 4.889

2.  Insights and Strategies to Revive Brachytherapy Using Social Media: A Google Trends Analysis.

Authors:  Kaidi Wang; Gary Lewis
Journal:  Cureus       Date:  2022-06-04

3.  Inter-fractional variations in the dosimetric parameters of accelerated partial breast irradiation using a strut-adjusted volume implant.

Authors:  Kotaro Iijima; Hiroyuki Okamoto; Kana Takahashi; Ako Aikawa; Akihisa Wakita; Satoshi Nakamura; Shie Nishioka; Ken Harada; Ryoichi Notake; Akimoto Sugawara; Ryoichi Yoshimura; Etsuo Kunieda; Jun Itami
Journal:  J Radiat Res       Date:  2020-01-23       Impact factor: 2.724

4.  Exploring the Mechanism of Baicalin Intervention in Breast Cancer Based on MicroRNA Microarrays and Bioinformatics Strategies.

Authors:  Anqi Ge; Lifang Liu; Xian'guang Deng; Jun Luo; Yanghua Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-20       Impact factor: 2.629

5.  Comparison of Breast Cancer Radiotherapy Techniques Regarding Secondary Cancer Risk and Normal Tissue Complication Probability - Modelling and Measurements Using a 3D-Printed Phantom.

Authors:  Marc Vogel; Jonas Gade; Bernd Timm; Michaela Schürmann; Hendrik Auerbach; Frank Nüsken; Christian Rübe; Patrick Melchior; Yvonne Dzierma
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

Review 6.  Prime Editing: An Emerging Tool in Cancer Treatment.

Authors:  Debmitra Sen; Sutripta Sarkar; Poulami Mukhopadhyay
Journal:  Mol Biotechnol       Date:  2022-10-17       Impact factor: 2.860

7.  Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer.

Authors:  Liangping Zhang; Yujun Zhang; Jianhang Bao; Wenshuo Gao; Dong Wang; Hao Pan
Journal:  Comput Math Methods Med       Date:  2022-09-29       Impact factor: 2.809

8.  Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma.

Authors:  Wei Chen; Yu Kun Luo; Ying Zhang; Qing Song; Jie Tang
Journal:  BMC Cancer       Date:  2021-07-20       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.